Heart-Saving pill may shield cancer patients from chemo damage
NCT ID NCT07245069
Summary
This study is testing whether a drug called dapagliflozin can protect the heart from damage caused by a common type of breast cancer chemotherapy. About 100 women receiving anthracycline chemotherapy will take either dapagliflozin or a placebo pill daily during treatment. Researchers will use heart ultrasounds, blood tests, and walking tests to see if the drug helps preserve heart and blood vessel function.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Medical Centre Ljubljana
RECRUITINGLjubljana, 1000, Slovenia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.